Determinants of recurrence in ITP treatment

Basit Öğe Kaydı
dc.contributor.authorDemircioglu, Sinan
dc.contributor.authorGurbuz, Ali Fuat
dc.date.accessioned2024-02-23T14:49:19Z
dc.date.available2024-02-23T14:49:19Z
dc.date.issued2020
dc.departmentNEÜen_US
dc.description.abstractObjective: Immune thrombocytopenia (ITP) is the most common cause of thrombocytopenia. Two-thirds of the cases respond to first-line therapy with corticosteroids. However, there is a 50% relapse rate six months after the treatment. Information predicting recurrence at the time of the diagnosis is limited. This study aimed to investigate the relationship of mean platelet volume (MPV) and the neutrophil/lymphocyte ratio (NLR) at the time of the diagnosis with ITP recurrence. Methods: The study included 171 adult primary ITP patients who received corticosteroids and/or intravenous immunoglobulin (IVIG) as first-line therapy. The relationship between the demographic characteristics of the patients and the laboratory values at the time of the diagnosis with the frequency of recurrence was evaluated. Results: A total of 126 (73.7%) female and 45 (26.3%) male patients with a mean age of 38.54 +/- 17.41 years were included in the study. 89 (52%) patients had a recurrence after first-line therapy. No relationship was found between the frequency of recurrence and age, gender, the presence of comorbid diseases, bleeding status, type of the first-line treatment, CRP, and MPV values. However, there was a statistically significant relationship between NLR increase and the frequency of recurrence (P=0.049). Conclusion: In this study, an association was found between the NLR levels and the rate of recurrence in ITP patients receivingfirst-line treatment. Further studies with larger sample sizes are needed to support this finding.en_US
dc.description.sponsorshipVan Yuzuncu Yil University Local Ethics Committee [12.10.2018/06]en_US
dc.description.sponsorshipThe study was approved by the Van Yuzuncu Yil University Local Ethics Committee (protocol number: 12.10.2018/06).en_US
dc.identifier.endpage1001en_US
dc.identifier.issn1940-5901
dc.identifier.issue2en_US
dc.identifier.startpage995en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12452/18121
dc.identifier.volume13en_US
dc.identifier.wosWOS:000518397600080en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherE-Century Publishing Corpen_US
dc.relation.ispartofInternational Journal Of Clinical And Experimental Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectImmune Thrombocytopeniaen_US
dc.subjectRecurrence Frequencyen_US
dc.subjectMean Platelet Volumeen_US
dc.subjectNeutrophil-Lymphocyte Ratioen_US
dc.titleDeterminants of recurrence in ITP treatmenten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu